Abstract
Bedaquiline remarkably improved treatment-related outcomes in patients with extensively drug resistant tuberculosis.
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Olayanju has nothing to disclose.
Conflict of interest: Dr. Limberis has nothing to disclose.
Conflict of interest: Dr. Esmail has nothing to disclose.
Conflict of interest: Dr. Oelofse has nothing to disclose.
Conflict of interest: Dr. Gina has nothing to disclose.
Conflict of interest: Dr. Pietersen has nothing to disclose.
Conflict of interest: Mr. Fadul has nothing to disclose.
Conflict of interest: Dr. Warren has nothing to disclose.
Conflict of interest: Dr. Dheda has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2018